Imunon, Inc. Files 8-K with Regulatory Updates

Ticker: IMNN · Form: 8-K · Filed: Jul 30, 2024 · CIK: 749647

Imunon, INC. 8-K Filing Summary
FieldDetail
CompanyImunon, INC. (IMNN)
Form Type8-K
Filed DateJul 30, 2024
Risk Levellow
Pages3
Reading Time3 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: 8-K, regulatory-disclosure, company-update

Related Tickers: IMNN

TL;DR

Imunon (IMNN) filed an 8-K on 7/30 detailing regulatory disclosures and other events.

AI Summary

Imunon, Inc. filed an 8-K on July 30, 2024, reporting on various events. The filing includes information related to Regulation FD disclosures, other events, and financial statements and exhibits. The company, formerly known as Celsion Corp, is incorporated in Delaware and headquartered in Lawrenceville, NJ.

Why It Matters

This 8-K filing provides important updates and disclosures from Imunon, Inc. to investors and the public regarding company events and financial information.

Risk Assessment

Risk Level: low — This filing is a routine 8-K reporting standard corporate events and disclosures, not indicating immediate financial distress or significant new risks.

Key Numbers

Key Players & Entities

FAQ

What specific events are being disclosed under Regulation FD?

The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in the excerpt.

What are the 'Other Events' reported in this 8-K?

The filing lists 'Other Events' as a category, but the specific nature of these events is not detailed in the provided text.

When was Imunon, Inc. formerly known as Celsion Corp?

The company was formerly known as Celsion Corp, with a date of name change listed as November 21, 2007.

What is Imunon, Inc.'s primary business classification?

Imunon, Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]' according to its Standard Industrial Classification.

Where is Imunon, Inc. headquartered?

Imunon, Inc.'s principal business address is located at 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648-2311.

Filing Stats: 750 words · 3 min read · ~3 pages · Grade level 8.3 · Accepted 2024-07-30 08:12:44

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IMUNON, INC. Dated: July 30, 2024 By: /s/ David Gaiero David Gaiero Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing